Related Experiment Videos
Hyaluronan microspheres for sustained gene delivery and site-specific targeting
Yang H Yun1, Douglas J Goetz, Paige Yellen
1Department of Biomedical Engineering, State University of New York, 348 Psychology A Building, Stony Brook, NY 11794-2580, USA.
Biomaterials
|October 29, 2003
Summary
Researchers developed novel hyaluronan microspheres for controlled drug delivery. This new method uses native hyaluronan and adipic dihydrazide crosslinking, enabling sustained DNA release and targeted delivery for biomedical applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Hyaluronan (HA) is a versatile biopolymer widely used in biomedical and cosmetic fields.
- Formulating native HA into microspheres for controlled delivery is challenging without organic solvents or chemical modification.
- Existing methods often require harsh conditions or alter HA's native properties.
Purpose of the Study:
- To develop a novel, efficient method for preparing native hyaluronan microspheres.
- To evaluate the potential of these microspheres for controlled DNA delivery and targeted cell binding.
- To establish a versatile platform for advanced biomedical applications.
Main Methods:
- Utilized adipic dihydrazide-mediated crosslinking chemistry to form HA microspheres from native hyaluronan.
- Incorporated plasmid DNA into the microspheres for gene delivery evaluation.
- Conjugated microspheres with monoclonal antibodies for cell-specific targeting.
Main Results:
- Successfully generated robust hyaluronan microspheres with a size distribution of 5-20 micrometers.
- Demonstrated sustained release of encapsulated plasmid DNA over several months, with successful in vitro and in vivo transfection capabilities.
- Showcased selective binding of antibody-conjugated microspheres to cells expressing E- and P-selectin receptors.
Conclusions:
- Developed a novel and efficient method for preparing native hyaluronan microspheres.
- The microspheres offer controlled DNA release and are suitable for gene therapy applications.
- The platform is adaptable for site-specific targeting, enhancing its potential in advanced medical treatments.